A Patient-Driven, Partner Focused Cell Therapy CDMO Equipped With:
Deep Scientific Expertise
Support autologous (patient-derived) and allogeneic (donor-derived) products across a variety of cell types / platforms including but not limited to CAR-T, NK, TCR, Treg, TIL, iPSC.
A purpose-built cell-therapy manufacturing facility thoughtfully designed for regulatory compliance and maximization of facility throughput.
Integration of Best-in-Class Cell Therapy Software Solutions
Integrated software solutions enable electronic batch records supporting real-time monitoring, testing and release of products, as well as management of complex product inbound and outbound logistics
Clinical and Commercial Manufacturing Capacity
Significant manufacturing capacity that is fully compliant with US and EU regulatory requirements for clinical and commercial manufacturing
Process and Analytical Development Laboratory
Large innovation laboratory with modular design to support process development programs in addition to innovation efforts.
Boutique & Adaptive Approach to Partner Relationships
Flexible, customized and differentiated solutions for technology transfer and cGMP manufacturing that resonate with partners
From Process Development to Clinical & Commercial Manufacturing
We provide end-to-end solutions for the development and manufacturing of autologous and allogeneic cell-based therapies